Preventing progression: smoldering myeloma

preview_player
Показать описание
Maria-Victoria Mateos, MD, PhD, University of Salamanca, Salamanca, Spain, discusses current advancements in smoldering myeloma. The risk of patients with smoldering myeloma progressing to multiple myeloma can vary. Various clinical markers exist to evaluate the risk and management of smoldering myeloma. Patients with a low risk can receive treatment similar to patients with monoclonal gammopathy of undetermined significance (MGUS), whereas patients with a high risk can benefit from early intervention such as receiving lenalidomide and dexamethasone. This interview took place during the 7th World Congress on Controversies in Multiple Myeloma (COMy), 2021.
  1. VJHemOnc – Video Journal of Hematology & HemOnc
  2. Speaker: Maria-Victoria Mateos
  3. Institution: University of Salamanca
  4. Event: COMy 2021
  5. Format: Interview
  6. Subject: Multiple Myeloma
Рекомендации по теме
Preventing progression: smoldering 0:02:18

Preventing progression: smoldering myeloma

Irene Ghobrial: Preventing 0:03:37

Irene Ghobrial: Preventing Progression from Smoldering to Symptomatic Myeloma

Preventing progression of 0:01:28

Preventing progression of smoldering myeloma to multiple myeloma with anti-myeloma therapies

A better understanding 0:02:44

A better understanding of smoldering myeloma to detect and prevent progression to multiple myeloma

Preventing progression to 0:03:28

Preventing progression to multiple myeloma

Mitigating smoldering myeloma 0:01:41

Mitigating smoldering myeloma progression risk

Identifying high-risk patients 0:03:04

Identifying high-risk patients with SMM & MGUS to prevent progression to active myeloma

What factors indicate 0:03:31

What factors indicate smoldering multiple myeloma (SMM) will progress to active myeloma?

Smoldering Multiple Myeloma 0:21:10

Smoldering Multiple Myeloma

Is the IMF’S 0:02:50

Is the IMF’S ASCENT trial curing smoldering myeloma patients?

When should smoldering 0:04:12

When should smoldering multiple myeloma patients start treatment?

Interpreting MGUS/Smoldering Myeloma 1:02:06

Interpreting MGUS/Smoldering Myeloma Labs- What To Know and When To Take Action

Multiple Myeloma: Smoldering 0:05:48

Multiple Myeloma: Smoldering myeloma, disease progression and changes in approach

How should smoldering 0:02:34

How should smoldering multiple myeloma be monitored?

Identifying high-risk smoldering 0:01:26

Identifying high-risk smoldering myeloma & minimizing treatment-related toxicity

Understanding the risk 0:01:11

Understanding the risk of progression of smoldering myeloma to provide more personalized therapies

Should we treat 0:02:43

Should we treat smoldering myeloma?

To treat or 0:01:29

To treat or not to treat smoldering myeloma & identifying patients at risk of progression to mye...

What is high-risk 0:04:47

What is high-risk smoldering myeloma? Criteria, risks, and ongoing research

Case 1: Patient 0:22:28

Case 1: Patient with high-risk smoldering myeloma

Better understanding smoldering 0:01:04

Better understanding smoldering myeloma & improving the outcomes of patients with high-risk myel...

Living Well with 0:56:51

Living Well with Myeloma: MGUS, Smoldering Myeloma, and Newly Diagnosed

Should smoldering myeloma 0:03:16

Should smoldering myeloma patients start treatment?

Blood screening for 0:02:18

Blood screening for MGUS: preventing progression with PROMISE